Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cato BioVentures
Boston (Bay Colony), Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Cato BioVentures is a venture capital affiliate of Cato Research, providing in-kind CRO service capital and investing in innovative therapeutics, medical devices, diagnostics, and platform technologies for improved drug discovery and development. It enables portfolio companies to achieve clinical and regulatory milestones with less reliance on other capital.[3]
- Modalities
- Small moleculeBiologicMedical deviceDiagnosticsPlatform technology
- Industry
- Investors
02
Partnerships
Cordex PharmaADial Pharmaceuticals
Beyond the preview
Go deeper on Cato BioVentures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cato BioVentures.